Skip to main content
Caplight Logo









Audion Therapeutics

Audion Therapeutics

Private
AmsterdamHealthcare & Life Scienceshttps://audiontherapeutics.com/

Last Round

Grant

Sep 7, 2015

Total Funding Raised

$9.26M

Company Overview

Audion Therapeutics is a biopharmaceutical company that develops regenerative therapies for the treatment of sensorineural hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinesensorineural hearing lossSNHLhair cell regenerationgamma-secretase inhibitorbiopharmaceuticalhearing loss cureintratympanic drug deliverydrug discoveryclinical-stage biotechotology researchsmall-molecule therapyhearing restorationbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Audion Therapeutics Comparables

Compare Audion Therapeutics with similar companies based on industry and business-model similarity.

Audion Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Salubritas Therapeutics
88%
AudioCure Pharma
86%
Sound Pharmaceuticals, Inc.
83%

Audion Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 7, 2015
Series BSep 7, 2015
Series AFeb 10, 2014

Key People

Founding team and executive leadership

Rolf Jan Rutten

CEO

Executive Team

Audion Therapeutics Investors

Notable investors and investment history

Audion Therapeutics investors
InvestorRounds
Inkef CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2014

    Eli Lilly and Company led the Series A round.

Audion Therapeutics Filings

Explore SEC and related filing metadata, where available.

Audion Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Audion Therapeutics's valuation, stock price, and market status.

Is Audion Therapeutics a public or private company?

Audion Therapeutics is a private company.

What is the current stock price of Audion Therapeutics?

Audion Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Audion Therapeutics worth (valuation)?

Valuation information for Audion Therapeutics is not publicly available.

Can I buy Audion Therapeutics stock?

Audion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Audion Therapeutics's last funding round?

Audion Therapeutics's most recent funding round was Grant on September 7, 2015.

Who are the main investors in Audion Therapeutics?

Key investors in Audion Therapeutics include Inkef Capital.

Will Audion Therapeutics IPO soon?

No public IPO plans have been announced for Audion Therapeutics.

How can I track Audion Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Audion Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range1
Year Founded2008
Last FundingSep 7, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?